Li‐Hua Lian

2.9k total citations
96 papers, 2.4k citations indexed

About

Li‐Hua Lian is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Li‐Hua Lian has authored 96 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 34 papers in Molecular Biology and 31 papers in Hepatology. Recurrent topics in Li‐Hua Lian's work include Liver Disease Diagnosis and Treatment (39 papers), Liver physiology and pathology (27 papers) and Alcohol Consumption and Health Effects (18 papers). Li‐Hua Lian is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Liver physiology and pathology (27 papers) and Alcohol Consumption and Health Effects (18 papers). Li‐Hua Lian collaborates with scholars based in China, South Korea and Japan. Li‐Hua Lian's co-authors include Ji‐Xing Nan, Yan‐Ling Wu, Ting Bai, Ying Wan, Quan Jin, Ben‐Wen Cui, Youli Yao, Ying‐Zi Jiang, Yong Yang and Peng Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and British Journal of Pharmacology.

In The Last Decade

Li‐Hua Lian

91 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐Hua Lian China 31 1.0k 679 540 388 324 96 2.4k
Xiaoying Wang China 26 1.1k 1.1× 343 0.5× 527 1.0× 297 0.8× 188 0.6× 98 2.8k
Xiaojiaoyang Li China 33 1.6k 1.5× 1.1k 1.5× 662 1.2× 542 1.4× 196 0.6× 98 3.4k
Ji‐Xing Nan China 37 1.5k 1.5× 901 1.3× 830 1.5× 592 1.5× 352 1.1× 122 3.4k
Shi-Bing Su China 30 1.3k 1.3× 538 0.8× 563 1.0× 311 0.8× 140 0.4× 125 2.9k
Ming Niu China 29 1.2k 1.2× 393 0.6× 887 1.6× 203 0.5× 244 0.8× 134 2.5k
Xing Lin China 25 603 0.6× 486 0.7× 336 0.6× 284 0.7× 164 0.5× 76 1.8k
Yujing Xia China 31 947 0.9× 755 1.1× 327 0.6× 519 1.3× 232 0.7× 59 2.4k
Xufeng Tao China 29 1.3k 1.3× 407 0.6× 267 0.5× 115 0.3× 253 0.8× 66 2.7k
Tzung-Yan Lee Taiwan 23 513 0.5× 512 0.8× 400 0.7× 273 0.7× 121 0.4× 71 1.8k
Tadayoshi Okumura Japan 31 965 0.9× 302 0.4× 338 0.6× 381 1.0× 136 0.4× 94 2.3k

Countries citing papers authored by Li‐Hua Lian

Since Specialization
Citations

This map shows the geographic impact of Li‐Hua Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Hua Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Hua Lian more than expected).

Fields of papers citing papers by Li‐Hua Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Hua Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Hua Lian. The network helps show where Li‐Hua Lian may publish in the future.

Co-authorship network of co-authors of Li‐Hua Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Hua Lian. A scholar is included among the top collaborators of Li‐Hua Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Hua Lian. Li‐Hua Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xueli, et al.. (2025). Thiazole isomers as potential ALK5 inhibitors alleviate P2X7R-mediated inflammation during liver fibrosis. International Immunopharmacology. 153. 114472–114472. 2 indexed citations
2.
Guo, Fang-Yan, et al.. (2025). Design and Synthesis of Betulinic Acid Derivatives as Antifibrotic Agents for Liver Fibrosis. Journal of Natural Products. 88(11). 2671–2682.
3.
Zhang, Zhihong, Hongxu Yang, Xueli Jiang, et al.. (2025). TLR3-mediated NET formation and macrophage activation in acute liver failure: Targeting IL-36 signaling to attenuate inflammatory drivers. International Immunopharmacology. 161. 115112–115112.
4.
Jiang, Min, Zhihong Zhang, Xiangyuan Wang, et al.. (2024). NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside. Phytomedicine. 131. 155783–155783. 4 indexed citations
5.
6.
Gao, Chong, et al.. (2024). Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling. Journal of Agricultural and Food Chemistry. 72(28). 15740–15754. 6 indexed citations
7.
Zhang, Zhihong, Min Jiang, Xiangyuan Wang, et al.. (2024). Casting NETs on Psoriasis: The modulation of inflammatory feedback targeting IL-36/IL-36R axis. International Immunopharmacology. 142(Pt B). 113190–113190. 5 indexed citations
8.
9.
Yang, Hongxu, et al.. (2023). Targeting RXFP1 by Ligustilide: A novel therapeutic approach for alcoholic hepatic steatosis. International Immunopharmacology. 127. 111460–111460. 6 indexed citations
10.
Jiang, Yuchen, Xin Han, Zhenyu Cui, et al.. (2022). Protective role of Siberian onions against toxin-induced liver dysfunction: an insight into health-promoting effects. Food & Function. 13(8). 4678–4690. 11 indexed citations
11.
Piao, Meihua, et al.. (2022). Taxifolin blocks monosodium urate crystal-induced gouty inflammation by regulating phagocytosis and autophagy. Inflammopharmacology. 30(4). 1335–1349. 11 indexed citations
12.
Jiang, Yuchen, et al.. (2021). Betulin Targets Lipin1/2-Meidated P2X7 Receptor as a Therapeutic Approach to Attenuate Lipid Accumulation and Metaflammation. Biomolecules & Therapeutics. 30(3). 246–256. 6 indexed citations
13.
Wu, Mei, et al.. (2020). Dihydroquercetin inhibits mouse hepatic steatosis induced by high fat diet feeding plus acute ethanol binge. 36(1). 147–148. 1 indexed citations
14.
Li, Ying, Yue Shang, Min Jiang, et al.. (2020). Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages. Inflammopharmacology. 28(6). 1481–1493. 29 indexed citations
15.
Yao, Youli, et al.. (2017). Acanthoic Acid Can Partially Prevent Alcohol Exposure-Induced Liver Lipid Deposition and Inflammation. Frontiers in Pharmacology. 8. 134–134. 20 indexed citations
16.
Yao, Youli, Xin Han, Jian Song, et al.. (2017). Acanthoic acid protectsagainst ethanol-induced liver injury: Possible role of AMPK activation and IRAK4 inhibition. Toxicology Letters. 281. 127–138. 13 indexed citations
17.
Bai, Ting, Li‐Hua Lian, Yan‐Ling Wu, Ying Wan, & Ji‐Xing Nan. (2013). Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells. International Immunopharmacology. 15(2). 275–281. 102 indexed citations
18.
Wan, Ying, Yan‐Ling Wu, Li‐Hua Lian, & Ji‐Xing Nan. (2012). Protective effect of <I>Ornithogalum saundersiae</I> Ait (Liliaceae) against acetaminophen-induced acute liver in-jury <I>via</I> CYP2E1 and HIF-1α. Chinese Journal of Natural Medicines. 10(3). 177–184. 9 indexed citations
19.
Wu, Yan‐Ling, Li‐Hua Lian, Ying‐Zi Jiang, & Ji‐Xing Nan. (2009). Hepatoprotective effects of salidroside on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. Journal of Pharmacy and Pharmacology. 61(10). 1375–1382. 47 indexed citations
20.
Park, Eun‐Jeon, Yuzhe Zhao, Li‐Hua Lian, Youn‐Chul Kim, & Dong Hwan Sohn. (2005). Skullcapflavone I fromScutellaria baicalensisInduces Apoptosis in Activated Rat Hepatic Stellate Cells. Planta Medica. 71(9). 885–887. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoying Wang Breakdown of academic impact, for papers by Xiaojiaoyang Li Breakdown of academic impact, for papers by Ji‐Xing Nan Breakdown of academic impact, for papers by Shi-Bing Su Breakdown of academic impact, for papers by Ming Niu Breakdown of academic impact, for papers by Xing Lin Breakdown of academic impact, for papers by Yujing Xia Breakdown of academic impact, for papers by Xufeng Tao Breakdown of academic impact, for papers by Tzung-Yan Lee Breakdown of academic impact, for papers by Tadayoshi Okumura
Rankless by CCL
2026